Reprise Biomedical
Glen Holden has over three decades of experience in the biomedical and medical device industries, currently serving as Executive Clinical Director at Reprise Biomedical since December 2022. Prior to this role, Glen held a notable tenure at Teleflex Incorporated from April 2002 to December 2022, progressing from Account Manager at Vascular Solutions, a Teleflex company, to Executive Account Manager. Further expertise was gained at Baystate Medical Center, where Glen worked in interventional radiology and the cardiac catheterization laboratory from January 1990 to February 2002.
This person is not in any offices
Reprise Biomedical
Reprise Biomedical is a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology that supports cellular integration. Reprise was created in connection with a spin-off from Miromatrix Medical Inc. in June 2019.